2 Clarke Drive
Cranbury, NJ 08512
© 2022 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
April 4th 2022
A discussion on the best way to sequence therapies for patients with MSI-high and MMR-proficient endometrial carcinoma.
March 24th 2022
Oncologists debate the proper treatment of a patient with a grade 2 endometrial carcinoma tumor.
March 18th 2022
Experts explain the need for germline testing and genetic counseling for patients with endometrial carcinoma as demonstrated by a patient case.
March 10th 2022
Drs Bradley Monk and David O’Malley explain dose reduction in endometrial carcinoma treatment based on clinical trial data.